191 related articles for article (PubMed ID: 12760879)
1. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.
Giacometti A; Cirioni O; Gov Y; Ghiselli R; Del Prete MS; Mocchegiani F; Saba V; Orlando F; Scalise G; Balaban N; Dell'Acqua G
Antimicrob Agents Chemother; 2003 Jun; 47(6):1979-83. PubMed ID: 12760879
[TBL] [Abstract][Full Text] [Related]
2. BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci.
Domenico P; Gurzenda E; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Korem M; Saba V; Scalise G; Balaban N
Peptides; 2004 Dec; 25(12):2047-53. PubMed ID: 15572191
[TBL] [Abstract][Full Text] [Related]
3. RNAIII Inhibiting Peptide (RIP) and Derivatives as Potential Tools for the Treatment of S. aureus Biofilm Infections.
Ciulla M; Di Stefano A; Marinelli L; Cacciatore I; Di Biase G
Curr Top Med Chem; 2018; 18(24):2068-2079. PubMed ID: 30345922
[TBL] [Abstract][Full Text] [Related]
4. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N
J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467
[TBL] [Abstract][Full Text] [Related]
5. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
Balaban N; Giacometti A; Cirioni O; Gov Y; Ghiselli R; Mocchegiani F; Viticchi C; Del Prete MS; Saba V; Scalise G; Dell'Acqua G
J Infect Dis; 2003 Feb; 187(4):625-30. PubMed ID: 12599079
[TBL] [Abstract][Full Text] [Related]
6. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation.
Anguita-Alonso P; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Saba V; Scalise G; Sevo M; Tuzova M; Patel R; Balaban N
Antimicrob Agents Chemother; 2007 Jul; 51(7):2594-6. PubMed ID: 17116671
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.
Balaban N; Cirioni O; Giacometti A; Ghiselli R; Braunstein JB; Silvestri C; Mocchegiani F; Saba V; Scalise G
Antimicrob Agents Chemother; 2007 Jun; 51(6):2226-9. PubMed ID: 17371825
[TBL] [Abstract][Full Text] [Related]
8. A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci.
Balaban N; Gov Y; Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; D'Amato G; Saba V; Scalise G; Bernes S; Mor A
Antimicrob Agents Chemother; 2004 Jul; 48(7):2544-50. PubMed ID: 15215107
[TBL] [Abstract][Full Text] [Related]
9. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection.
Simonetti O; Cirioni O; Mocchegiani F; Cacciatore I; Silvestri C; Baldassarre L; Orlando F; Castelli P; Provinciali M; Vivarelli M; Fornasari E; Giacometti A; Offidani A
Int J Mol Sci; 2013 Aug; 14(8):16321-32. PubMed ID: 23965956
[TBL] [Abstract][Full Text] [Related]
11. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP.
Balaban N; Stoodley P; Fux CA; Wilson S; Costerton JW; Dell'Acqua G
Clin Orthop Relat Res; 2005 Aug; (437):48-54. PubMed ID: 16056025
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic Susceptibility of Staphylococcus aureus Plankton and Biofilm Forms Isolated in Implant-Associated Infection.
Babushkina IV; Mamonova IA; Ulyanov VY; Gladkova EV; Shpinyak SP
Bull Exp Biol Med; 2021 Nov; 172(1):46-48. PubMed ID: 34792719
[TBL] [Abstract][Full Text] [Related]
13. Oligomerization of RNAIII-Inhibiting Peptide Inhibits Adherence and Biofilm Formation of Methicillin-Resistant Staphylococcus aureus In Vitro and In Vivo.
Zhou Y; Zhao R; Ma B; Gao H; Xue X; Qu D; Li M; Meng J; Luo X; Hou Z
Microb Drug Resist; 2016 Apr; 22(3):193-201. PubMed ID: 26571297
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
[TBL] [Abstract][Full Text] [Related]
15. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
[TBL] [Abstract][Full Text] [Related]
16. RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection.
Cirioni O; Ghiselli R; Minardi D; Orlando F; Mocchegiani F; Silvestri C; Muzzonigro G; Saba V; Scalise G; Balaban N; Giacometti A
Antimicrob Agents Chemother; 2007 Dec; 51(12):4518-20. PubMed ID: 17875996
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
[TBL] [Abstract][Full Text] [Related]
18. RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Mocchegiani F; Orlando F; D'Amato G; Rocchi M; Scalise G; Saba V
Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):603-7. PubMed ID: 15121110
[TBL] [Abstract][Full Text] [Related]
19. Deferiprone and Gallium-Protoporphyrin Have the Capacity to Potentiate the Activity of Antibiotics in
Richter K; Thomas N; Zhang G; Prestidge CA; Coenye T; Wormald PJ; Vreugde S
Front Cell Infect Microbiol; 2017; 7():280. PubMed ID: 28690982
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
Morikawa K; Nonaka M; Yoshikawa Y; Torii I
Int J Antimicrob Agents; 2005 Jan; 25(1):44-50. PubMed ID: 15620825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
